Education
About Us
Working with TipRanks
Follow Us
Adam Crystal Insider Profile
4 Followers
Adam Crystal, CMO at C4 Therapeutics, holds 158.21K shares in Tango Therapeutics (Ticker: TNGX), holds 20.10K shares in C4 Therapeutics (Ticker: CCCC). Most recently, Adam Crystal Sold ― shares of Tango Therapeutics on Feb 06, 2025 for an estimated value of 43.80K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+56.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Adam Crystal holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 08, 2024 - Feb 08, 2025
Return:+75.00%
The most profitable trade made by Adam Crystal
Adam Crystal's Trading History
C4 Therapeutics
Feb 01, 2023
CMO
Uninformative Buy
19.05K
$47.43K
Tango Therapeutics
Feb 06, 2025
President, Research & Development
Informative Sell
43.80K
$318.00K
List of latest transactions for each holding click on a transaction to see Adam Crystal's performance on stock
You May Also Like
Adam Crystal insider profile FAQ
What is the percentage of profitable transactions made by Adam Crystal?
The percentage of profitable transactions made by Adam Crystal is 100%.
What is the average return per transaction made by Adam Crystal?
The average return per transaction made by Adam Crystal is 56.60%.
What stocks does Adam Crystal hold?
Adam Crystal holds: CCCC, TNGX stocks.
What was Adam Crystal’s latest transaction?
Adam Crystal latest transaction was an Informative Sell of $43.80K.
What was Adam Crystal's most profitable transaction?
Adam Crystal’s most profitable transaction was an Informative Sell of TNGX stock on February 8, 2024. The return on the trade was 75.00%.
What is Adam Crystal's role in C4 Therapeutics?
Adam Crystal's role in C4 Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.